AMARNA THERAPEUTICS
Based on its unique properties SVac is ideally suited for developing next generation effective gene and immune-therapies. In order to realize our ambition to become the leading global gene therapy company they formed a worldwide consortium of key players in the virology, vector production, immunology, ophthalmology, oncology, neurology and gene therapy fields of research. With major regulatory, legal and intellectual property firms, they are developing a range of innovative and effective interventions for genetic disorders, degenerative diseases, allergies and cancer. Interventions that will dramatically improve patients’ life expectancy and quality and moreover will significantly reduce the health care costs of the society in general.
AMARNA THERAPEUTICS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2008-01-01
Address:
Leiden, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.amarnatherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
15 M EUR
Technology used in webpage:
ReCAPTCHA Google Maps API Google Maps For Work German Server Location
Similar Organizations
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Human stem cells institute PJSC
Human stem cells institute PJSC is a privately held company operates as a biotech company.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Relief Therapeutics
Relief Therapeutics is a clinical stage biotechnology company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Investors List
Eurostars
Eurostars investment in Grant - Amarna Therapeutics
Flerie Invest
Flerie Invest investment in Venture Round - Amarna Therapeutics
C4 Ventures
C4 Ventures investment in Venture Round - Amarna Therapeutics
Netherlands Enterprise Agency
Netherlands Enterprise Agency investment in Debt Financing - Amarna Therapeutics
Flerie Invest
Flerie Invest investment in Venture Round - Amarna Therapeutics
Pim Berger
Pim Berger investment in Venture Round - Amarna Therapeutics
Key Employee Changes
Official Site Inspections
http://www.amarnatherapeutics.com
- Host name: s20998836.onlinehome-server.info
- IP address: 217.160.183.146
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Amarna Therapeutics"
About us - Amarna Therapeutics
Thomas was the co-founder of Recipharm AB, a Swedish pharmaceutical contract development and manufacturing company, in 1995. Under his leadership, the organization grew to be a …See details»
Amarna Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Based on its unique properties SVac is ideally suited for developing next generation effective gene and immune-therapies. In order to realize …See details»
Amarna Therapeutics - Overview, News & Similar companies
Jun 7, 2023 Amarna Therapeutics contact info: Phone number: +31 647566999 Website: www.amarnatherapeutics.com What does Amarna Therapeutics do? Amarna Therapeutics is …See details»
Amarna Therapeutics - LinkedIn
Amarna Therapeutics is a privately held, pre-clinical biotech company developing transformative, potentially curative gene therapies for a range of both rare and prevalent diseases.See details»
Amarna Therapeutics - PitchBook
Amarna Therapeutics General Information Description. Operator of a biotechnology company intended to develop transformative, potentially curative gene therapies for a range of both rare …See details»
Amarna Therapeutics - Products, Competitors, Financials, …
Amarna Therapeutics is a biotech company focused on the development of gene therapies. Use the CB Insights Platform to explore Amarna Therapeutics's full profile.See details»
Amarna Therapeutics Partners with NorthX Biologics to
4 days ago NorthX Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), has expertise in producing cell and gene therapies, …See details»
Amarna Therapeutics secures additional €5 ($5.7) million to …
Dec 1, 2021 For this, Amarna has recently engaged HALIX, a leading biopharmaceutical contract development and manufacturing organization (CDMO), to produce the clinical trial …See details»
Press Release - Amarna Therapeutics
Jan 11, 2022 Redoxis is a Swedish Clinical Research Organization (CRO) with core expertise and focus on preclinical drug development and efficacy evaluation in models of inflammatory …See details»
Amarna Therapeutics | VentureRadar
Website: http://www.amarnatherapeutics.com/ Develops transformative gene therapies using SV40-derived vectors for genetic disorders, autoimmune diseases, and chronic ...See details»
Amarna Therapeutics Partners with NorthX Biologics to Advance …
4 days ago A Shared Vision for Transformative Gene Therapy This partnership highlights the shared commitment of Amarna Therapeutics and NorthX Biologics to advance innovative …See details»
Amarna Therapeutics Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Amarna Therapeutics. See Amarna Therapeutics company profile and funding data.See details»
Amarna Therapeutics Partners with NorthX Biologics to Advance …
4 days ago About NorthX Biologics NorthX Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), has expertise in producing cell and …See details»
Press Release - Amarna Therapeutics
Leiden, The Netherlands, 28th November 2024 - Amarna Therapeutics, (“Amarna” or “the Company”), a privately held biotechnology company specializing in transformative gene …See details»
Amarna Therapeutics BV (Amarna Therapeutics BV) - 药物管线_专 …
了解Amarna Therapeutics BV (Amarna Therapeutics BV)公司的药物管线，治疗领域，技术平台，以及它的5篇新闻，疾病领域:内分泌与代谢疾病，血液及淋巴系统疾病，免疫系统疾病，神 …See details»
Press Release - Amarna Therapeutics
Dec 1, 2021 The company is currently completing IND enabling studies and has initiated manufacturing with the aim of starting a Phase 1/2a trial in approximately two years. For this, …See details»
Makana Therapeutics - Delivering Hope for the Future of …
Makana Therapeutics. Founded in 2009, Makana Therapeutics is focused on developing pigs with reduced xenoantigen expression, making human transplantation of cells, tissues and organs …See details»
Working here - Amarna Therapeutics
Joined: 2008. Personal statement: Having been employed at Amarna since its earliest days and in my role as Team Lead assay development, I am really enthusiastic to be part of the journey …See details»
Press releases - Amarna Therapeutics
Dutch Amarna Therapeutics enters research collaboration with Spanish FPS, examining the efficacy of its SV40-based SVecTM gene delivery vector platform technology in diabetes …See details»